Integra LifeSciences (IART)
(Real Time Quote from BATS)
$28.45 USD
-0.93 (-3.17%)
Updated Apr 25, 2024 03:16 PM ET
3-Hold of 5 3
A Value D Growth A Momentum A VGM
- YR Estimate
- 12/31/2023
- 12/31/2022
- 12/31/2021
- 12/31/2020
- 12/31/2019
- Revenue - Line of Business (LOBR)
- Revenue: Codman Specialty Surgical: Total
- 1,058.99
- 1,019.56
- 1,025.23
- 894.83
- 996.21
- Revenue - Line of Business (LOBR)
- Revenue: Tissue Technologies: Total
- 482.58
- 538.10
- 517.22
- 477.04
- 521.35
- Revenue - Line of Business (LOBR)
- Revenue: Codman Specialty Surgical: Neurosurgery
- 818.10
- 794.02
- 802.96
- 716.34
- 767.79
- Revenue - Line of Business (LOBR)
- Revenue: Codman Specialty Surgical: Instruments
- 240.89
- 225.55
- 222.27
- 178.49
- 228.41
- Revenue - Line of Business (LOBR)
- Revenue: Tissue Technologies: Wound Reconstruction and Care
- 373.99
- 406.69
- 392.46
- 293.04
- 322.74
- Revenue - Line of Business (LOBR)
- Revenue: Tissue Technologies: Private Label
- 108.59
- 131.41
- 124.75
- 105.68
- 108.53
- Revenue - Geographic (GEOR)
- Geographic Revenues: United States
- 1,100.73
- 1,126.81
- 1,089.53
- 971.98
- 1,077.38
- Revenue - Geographic (GEOR)
- Geographic Revenues: Europe
- 165.22
- 170.90
- 191.33
- 172.69
- 197.47
- Revenue - Geographic (GEOR)
- Geographic Revenues: Asia Pacific
- 193.10
- 176.48
- 182.03
- 157.17
- 157.39
- Revenue - Geographic (GEOR)
- Geographic Revenues: Rest of world
- 82.53
- 83.48
- 79.56
- 70.03
- 85.32
- Non Financial / Operating Metric (NFM)
- Organic Revenue Growth
- 0.00
- 4.20
- 14.20
- -8.70
- 4.80